Am J Physiol Cell Physiol Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 279: C990-C998, 2000;
0363-6143/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Fusco, F.
Right arrow Articles by Anand-Srivastava, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Fusco, F.
Right arrow Articles by Anand-Srivastava, M. B.
Vol. 279, Issue 4, C990-C998, October 2000

Volume overload cardiac hypertrophy exhibits decreased expression of Gsalpha and not of Gialpha in heart

Francesco Di Fusco, Shehla Hashim, and Madhu B. Anand-Srivastava

Department of Physiology and Groupe de Recherche sur le Système Nerveux Autonome, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada H3C 3J7

We have recently reported enhanced levels of Gialpha proteins in genetic and other experimentally induced models of hypertension, whereas the levels of Gsalpha were decreased in hypertensive rats expressing cardiac hypertrophy. The present studies were undertaken to investigate whether the decreased levels of Gsalpha are associated with cardiac hypertrophy per se and used an aortocaval fistula (AV shunt; volume overload) rat model that exclusively expresses cardiac hypertrophy. Cardiac hypertrophy in Sprague-Dawley rats (200-250 g) was induced under anesthesia, and, after a period of 10 days, the hearts were used for adenylyl cyclase activity determination, protein quantification, and mRNA level determination. A temporal relationship between the expression of Gsalpha proteins and cardiac hypertrophy was also examined on days 2, 3, 7, and 10 after induction of AV shunt in the rat. The heart-to-body-weight ratio (mg/g) was significantly increased in AV shunt rats after 3, 7, and 10 days of induction of AV shunt compared with sham-operated controls, whereas arterial blood pressure was not different between the two groups. Guanosine 5'-O-(3-thiotriphosphate) (GTPgamma S) stimulated adenylyl cyclase activity in a concentration-dependent manner in heart membranes from both groups; however, the degree of stimulation was significantly decreased in AV shunt rats. In addition, the stimulatory effects of isoproterenol were also diminished in AV shunt rats compared with control rats, whereas glucagon-stimulated adenylyl cyclase activity was not different in the two groups. The inhibitory effects of oxotremorine (receptor-dependent Gi functions) and low concentrations of GTPgamma S on forskolin-stimulated adenylyl cyclase activity (receptor-independent Gi functions) were not different in the two groups. In addition forskolin and NaF also stimulated adenylyl cyclase activity to a lesser degree in AV shunt rats compared with control rats. The levels of Gialpha -2 and Gialpha -3 proteins and mRNA, as determined by immunoblotting and Northern blotting, respectively, were not different in both groups; however, the levels of Gsalpha 45 and Gsalpha 47, and not of Gsalpha 52, proteins were significantly decreased in AV shunt rats by days 7 and 10 compared with control rats, whereas no change was observed on days 2 and 3 after induction of AV shunt. These results suggest that the decreased expression of Gsalpha proteins may not be the cause but the effect of hypertrophy and that the diminished responsiveness of adenylyl cyclase to GTPgamma S, isoproterenol, NaF, and forskolin in hearts from AV shunt rats may partly be due to the decreased expression of Gsalpha . It can be concluded from these studies that the decreased expression of Gsalpha may be associated with cardiac hypertrophy and not with arterial hypertension.

G protein; adenylyl cyclase; aortocaval fistula; AV shunt


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
S. C. Kolwicz, H. Kubo, S. M. MacDonnell, S. R. Houser, and J. R. Libonati
Effects of forskolin on inotropic performance and phospholamban phosphorylation in exercise-trained hypertensive myocardium
J Appl Physiol, February 1, 2007; 102(2): 628 - 633.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Wang, E. Sentex, D. Chapman, and N. S. Dhalla
Alterations of adenylyl cyclase and G proteins in aortocaval shunt-induced heart failure
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H118 - H125.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online